Latest
ad-hoc-news.de Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 152
- Sources here
- 20
- Companies here
- 12
Search results
Stored financial headlines
Active search
152 matching headlines
Ticker or company: ESENMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Fresenius Medical Care stock holds steady near $24 as investors digest latest capital market update
Fresenius Medical Care stock is trading near $24, with a slight decline of 0.67% on the NYSE and 0.28% in Europe, as investors analyze the company's latest capital market update. This update details recent share repurchases and trading activity, suggesting a strategy to optimize …
FMS
main company
Sharemaestro market context
Trend signal active
52 weeks -3.4%
Royal Bank of Canada Purchases 179,418 Shares of Fresenius Medical Care AG & Co. KGaA $FMS
Royal Bank of Canada significantly increased its stake in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 479.2% in the first quarter, acquiring 179,418 additional shares. This brings their total holdings to 216,861 shares, valued at approximately $4.9 million. Despite the substantial purchase, …
FMS
main company
Sharemaestro market context
Trend signal active
52 weeks -3.4%
Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026, at 9:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer and Chair of the Management Board - Helen Giza Chief Financial Officer - Martin Fischer Investor Relations - Dominik Heger Full Conference Call Transcript Operator: …
Sharemaestro market context Price below Trend Line 52 weeks -51.0% · Next-week setup negative 3.6%Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong …
FRE
main company
Sharemaestro market context
Price above Trend Line
52 weeks +1.5% · Next-week setup positive 59.6%
Why (IRS) Price Action Is Critical for Tactical Trading
This article analyzes the price action of Irsa Inversiones Y Representaciones S.a. (NYSE: IRS), highlighting a weak near-term sentiment challenging long-term strength. It presents institutional trading strategies including long, breakout, and short positions, along with multi-timeframe signal analysis. The report identifies an exceptional 51.5:1 …
IRS
main company
Sharemaestro market context
Price below Trend Line
52 weeks +6.7% · Next-week setup positive 56.7%
IRSA Inversiones Number of Employees 2026 | Employee Count & Headcount Data
IRSA Inversiones y Representaciones SA (IRSA) had approximately 1,832 employees worldwide as of March 2026, marking a 16.1% growth from 2023. The company is actively hiring, though its job postings declined significantly in 2026. Most of its workforce is based in South America, with …
IRS
main company
Sharemaestro market context
Price below Trend Line
52 weeks +6.7% · Next-week setup positive 56.7%
Fresenius Medical Care AG & Co. KGaA $FMS Position Boosted by Sei Investments Co.
Sei Investments Co. significantly increased its stake in Fresenius Medical Care AG & Co. KGaA by 80.7%, now owning 120,704 shares. Other institutional investors like Morgan Stanley and Bank of America also boosted their positions, although overall institutional ownership remains at 8.37%. Despite beating …
FMS
main company
Sharemaestro market context
Trend signal active
52 weeks -3.4%
Fresenius Medical Care AG 2026 Q2 - Results - Earnings Call Presentation (NYSE:FMS) 2026-08-07
Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026, at 9:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer and Chair of the Management Board - Helen Giza Chief Financial Officer - Martin Fischer Investor Relations - Dominik Heger Full Conference Call Transcript Operator: …
FMS
main company
Sharemaestro market context
Trend signal active
52 weeks -3.4%
Barclays Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Barclays has maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X) with a price target of €44.50. This rating aligns with Goldman Sachs's Hold, while Jefferies reiterated a Sell rating on the company. Fresenius Medical Care currently has a market …
FMS
main company
Sharemaestro market context
Trend signal active
52 weeks -3.4%
Arrowstreet Capital Limited Partnership Trims Holdings in IRSA Inversiones Y Representaciones S.A. $IRS
Arrowstreet Capital Limited Partnership reduced its stake in IRSA Inversiones Y Representaciones S.A. (NYSE:IRS) by 68% in the first quarter, selling 150,782 shares and retaining 70,930 shares valued at approximately $1.15 million. Despite this, institutional investors collectively own 45.46% of the company, with many …
IRS
main company
Sharemaestro market context
Price below Trend Line
52 weeks +6.7% · Next-week setup positive 56.7%
Fresenius Medical Care Launches 4008A™Dialysis Machine in China
Fresenius Medical Care has launched its 4008A™ dialysis machine in China, aiming to provide high-quality, cost-effective dialysis treatment to more patients suffering from end-stage renal disease (ESRD). The machine, a collaboration between their Chinese and German R&D teams, is designed to enhance accessibility and …
FMS
main company
Sharemaestro market context
Trend signal active
52 weeks -3.4%
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives Average Rating of "Reduce" from Brokerages
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has received an average rating of "Reduce" from eleven brokerage firms, with five recommending a sell and six a hold. The average 12-month price target is $22.45, below its opening price of $23.91. Despite the "Reduce" …
FMS
main company
Sharemaestro market context
Trend signal active
52 weeks -3.4%
Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda
Organic revenue growth1 of 5% with growth in all operating segments Operating income2 grew by 23%, resulting in further margin expansion to 11.7% Reported operating income grew by 10% and reported net income3 decreased by 3% Earnings per share2 (EPS) increased by 28%, supported …
Sharemaestro market context Price below Trend Line 52 weeks -51.0% · Next-week setup negative 3.6%Fresenius SE & Co KGaA (FSNUY) (Q2 2026) Earnings Call Highlights: Raises Full-Year EPS ...
This article first appeared on GuruFocus. Release Date: August 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Fresenius SE & Co. KGaA (FSNUY) raised its full-year core EPS growth guidance to 10%-15% …
FRE
main company
Sharemaestro market context
Price above Trend Line
52 weeks +1.5% · Next-week setup positive 59.6%
Jefferies Remains a Sell on Fresenius Medical Care AG & Co. KGaA (0H9X)
Jefferies analyst James Vane maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X) with a price target of €31.00. This follows similar Sell ratings from UBS and a Hold rating from Bernstein on the same day. The article notes the …
FMS
main company
Sharemaestro market context
Trend signal active
52 weeks -3.4%
FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand
Fresenius Medical Care AG FMS reported second-quarter 2026 adjusted earnings per share (EPS) of 66 cents, which increased 28% year over year at constant currency (cc), supported by stronger Care Delivery profitability and share repurchases. FMS Posts Solid Organic Revenue Growth Revenues rose 0.9% …
Sharemaestro market context Price below Trend Line 52 weeks -51.0% · Next-week setup negative 3.6%Fresenius Medical Care (XTRA:FME) Expands BEACON US To Build Its Case For HVHDF
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Fresenius Medical Care is expanding its BEACON-US clinical initiative to build real-world evidence for high-volume hemodiafiltration therapy in the U.S. The program evaluates …
Sharemaestro market context Price below Trend Line 52 weeks -51.0% · Next-week setup negative 3.6%